CARDIFF ONCOLOGY, INC.: 10-Q filed 2014-11-06

Name: CARDIFF ONCOLOGY, INC.: 10-Q filed 2014-11-06
Creator: CARDIFF ONCOLOGY, INC.

What CARDIFF ONCOLOGY, INC. reported in its quarterly report filed 2014-11-06 (fiscal Q3 2014): 26 published measures, 63 facts as tagged in accession 0001104659-14-077681.

This filing

Form: 10-Q (quarterly report)
Filed: 2014-11-06
Fiscal period: fiscal Q3 2014
Accession: 0001104659-14-077681 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CARDIFF ONCOLOGY, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2014-09-30	32,762,283	USD
At 2013-12-31	27,155,735	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2014-09-30	20,408,527	USD
At 2013-12-31	6,763,735	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2014-09-30	12,353,756	USD
At 2013-12-31	20,392,000	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2014-10-31	30,000,000	USD
At 2014-09-30	31,163,559	USD
At 2013-12-31	25,836,937	USD
At 2013-06-30	27,799,387	USD
At 2012-12-31	10,819,781	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2014-07-01 to 2014-09-30	-5,375,217	USD	92
2014-01-01 to 2014-09-30	-9,642,105	USD	273
2013-07-01 to 2013-09-30	-4,401,232	USD	92
2013-01-01 to 2013-09-30	-10,782,018	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2014-01-01 to 2014-09-30	235,623	USD	273
2013-01-01 to 2013-09-30	571,097	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2014-09-30	-76,702,470	USD
At 2013-12-31	-67,043,410	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2014-09-30	841,434	USD
At 2013-12-31	750,565	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2014-01-01 to 2014-09-30	1,384,959	USD	273
2013-01-01 to 2013-09-30	1,856,684	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2014-07-01 to 2014-09-30	-3,940,228	USD	92
2014-01-01 to 2014-09-30	-10,441,463	USD	273
2013-07-01 to 2013-09-30	-3,077,653	USD	92
2013-01-01 to 2013-09-30	-7,841,604	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2014-09-30	31,573,947	USD
At 2013-12-31	26,068,720	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2014-07-01 to 2014-09-30	389,871	USD	92
2014-01-01 to 2014-09-30	454,082	USD	273
2013-07-01 to 2013-09-30	6,263	USD	92
2013-01-01 to 2013-09-30	6,931	USD	273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2014-09-30	3,122,433	USD
At 2013-12-31	2,008,866	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2014-09-30	461,769	USD
At 2013-12-31	286,608	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2014-09-30	62,370	USD
At 2013-12-31	78,994	USD

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2014-09-30	18,902,783	shares
At 2013-12-31	18,902,783	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2014-09-30	89,054,276	USD
At 2013-12-31	87,433,460	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2014-09-30	346,902	USD
At 2013-12-31	336,450	USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2014-09-30	96,060	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2014-09-30	1,907,930	USD
At 2013-12-31	1,524,092	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2014-09-30	348,018	USD
At 2013-12-31	152,789	USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2014-07-01 to 2014-09-30	-5,381,277	USD	92
2014-01-01 to 2014-09-30	-9,659,060	USD	273
2013-07-01 to 2013-09-30	-4,406,592	USD	92
2013-01-01 to 2013-09-30	-10,802,648	USD	273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2014-07-01 to 2014-09-30	1,466,592	USD	92
2014-01-01 to 2014-09-30	4,135,310	USD	273
2013-07-01 to 2013-09-30	1,875,427	USD	92
2013-01-01 to 2013-09-30	4,235,776	USD	273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2014-01-01 to 2014-09-30	169,599	USD	273
2013-01-01 to 2013-09-30	85,532	USD	273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2013-01-01 to 2013-09-30	18,897,388	USD	273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2014-01-01 to 2014-09-30	-16,624	USD	273
2013-01-01 to 2013-09-30	-98,815	USD	273

Inspect the source

Entity: CARDIFF ONCOLOGY, INC. / CIK 0001213037
Captured: 2026-09-20T07:45:48.177Z
SEC response SHA-256: 5fefa7380123168da913afadb8db67f9296559e6467fa58ab3879c6c623fb326

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001213037.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))